Monthly Archives: August 2013

Innovations in Stent Design

Stent technology continues to evolve at a rapid pace. Second-generation DESs have alleviated the safety concerns of late stent thrombosis by addressing issues of polymer biocompatibility and stent design, and optimizing drug loads and release kinetics. Two articles in this … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , | Leave a comment

“Thromboembolism”: A Rare But Crucial Cause of Acute Myocardial Infarction

By Yukari Kobayashi, MD When you see a patient presenting with cardiogenic shock and ST elevation myocardial infarction, especially when the electrocardiogram pattern suggests left main occlusion, you would refer him to the cardiac catheterization laboratory as soon as possible. … Continue reading

Posted in Uncategorized | Leave a comment

Cardiac Resynchronization Therapy Method Could Advance Further

by Mark Arokiaraj This is a theoretical method to augment ventricular contraction using electro-active polymers in the conventional cardiac resynchronization therapy method. Also the model could be improvised with left ventricular endocardial pacing wire carrying a MR reduction device, which … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

The Quest for Optimal Reperfusion Therapy Continues

Optimal myocardial reperfusion is a well-recognized contributor to lower mortality rates after PCI for ST-elevation myocardial infarction (STEMI). Manual thrombus aspiration and intravenous (IV) administration of glycoprotein IIb/IIa receptor inhibitors (GPIs) improves myocardial reperfusion and clinical outcomes. Recently, observational and … Continue reading

Posted in Uncategorized | Tagged , , , , , , , | Leave a comment